The study was performed within the Department of Nephrology at one tertiary referral institution in New SouthWales, Australia. Adult patients currently receiving HD were recruited, providing they met the following eligibility criteria: a) were aged >18 years; and b) had been on HD for at least six months. All patients provided informed consent to participate.